Literature DB >> 30916460

DNAzyme-Loaded Metal-Organic Frameworks (MOFs) for Self-Sufficient Gene Therapy.

Huimin Wang1, Yuqi Chen2, Hong Wang1, Xiaoqing Liu1, Xiang Zhou2, Fuan Wang1.   

Abstract

DNAzymes have been recognized as potent therapeutic agents for gene therapy, while their inefficient intracellular delivery and insufficient cofactor supply precludes their practical biological applications. Metal-organic frameworks (MOFs) have emerged as promising drug carriers without in-depth consideration of their disassembled ingredients. Herein, we report a self-sufficient MOF-based chlorin e6-modified DNAzyme (Ce6-DNAzyme) therapeutic nanosystem for combined gene therapy and photodynamic therapy (PDT). The ZIF-8 nanoparticles (NPs) could efficiently deliver the therapeutic DNAzyme without degradation into cancer cells. The pH-responsive ZIF-8 NPs disassemble with the concomitant release of the guest DNAzyme payloads and the host Zn2+ ions that serve, respectively, as messenger RNA-targeting agent and required DNAzyme cofactors for activating gene therapy. The auxiliary photosensitizer Ce6 could produce reactive oxygen species (ROS) and provide a fluorescence signal for the imaging-guided gene therapy/PDT.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  DNAzymes; drug delivery; gene therapy; metal-organic frameworks; photodynamic therapy

Year:  2019        PMID: 30916460     DOI: 10.1002/anie.201902714

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  17 in total

1.  Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma.

Authors:  Le-Le Zhou; Qun Guan; Wei Zhou; Jing-Lan Kan; Yu-Bin Dong
Journal:  Chem Sci       Date:  2022-06-15       Impact factor: 9.969

2.  Accelerated FeIII/FeII redox cycle of Fenton reaction system using Pd/NH2-MIL-101(Cr) and hydrogen.

Authors:  Zhong-Xing Liu; Xin Liu; Yong Li; Shi-Qian Gao
Journal:  Turk J Chem       Date:  2021-04-28       Impact factor: 1.239

3.  Zn2+-dependent DNAzymes that cleave all combinations of ribonucleotides.

Authors:  Rika Inomata; Jing Zhao; Makoto Miyagishi
Journal:  Commun Biol       Date:  2021-02-16

4.  Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.

Authors:  Xuehua Chen; Yongquan Huang; Hui Chen; Ziman Chen; Jiaxin Chen; Hao Wang; Dan Li; Zhongzhen Su
Journal:  J Nanobiotechnology       Date:  2022-01-15       Impact factor: 9.429

5.  Efficient oral insulin delivery enabled by transferrin-coated acid-resistant metal-organic framework nanoparticles.

Authors:  Jun-Jie Zou; Gaohui Wei; Chuxiao Xiong; Yunhao Yu; Sihui Li; Liefeng Hu; Shengqian Ma; Jian Tian
Journal:  Sci Adv       Date:  2022-02-23       Impact factor: 14.136

6.  Regulation of redox balance using a biocompatible nanoplatform enhances phototherapy efficacy and suppresses tumor metastasis.

Authors:  Qunying Jiang; Min Pan; Jialing Hu; Junlin Sun; Lei Fan; Zhiqiao Zou; Jianshuang Wei; Xiaoquan Yang; Xiaoqing Liu
Journal:  Chem Sci       Date:  2020-10-22       Impact factor: 9.825

Review 7.  DNA Assembly-Based Stimuli-Responsive Systems.

Authors:  Shasha Lu; Jianlei Shen; Chunhai Fan; Qian Li; Xiurong Yang
Journal:  Adv Sci (Weinh)       Date:  2021-05-14       Impact factor: 16.806

8.  An intelligent ZIF-8-gated polydopamine nanoplatform for in vivo cooperatively enhanced combination phototherapy.

Authors:  Jie Feng; Wenqian Yu; Zhen Xu; Fuan Wang
Journal:  Chem Sci       Date:  2020-01-10       Impact factor: 9.825

Review 9.  In vitro Selection of Chemically Modified DNAzymes.

Authors:  Po-Jung Jimmy Huang; Juewen Liu
Journal:  ChemistryOpen       Date:  2020-10-19       Impact factor: 2.630

10.  Advanced Cancer Starvation Therapy by Simultaneous Deprivation of Lactate and Glucose Using a MOF Nanoplatform.

Authors:  Jiantao Yu; Zixiang Wei; Qing Li; Feiyan Wan; Zhicong Chao; Xindan Zhang; Li Lin; Hong Meng; Leilei Tian
Journal:  Adv Sci (Weinh)       Date:  2021-08-07       Impact factor: 16.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.